ebook Munafa Stock Market Course + Intraday & FNO calls  

       

532523 announcements Biocon Ltd. announcements and dividends declared BSE

Biocon Ltd. Complete list of announcements declared & dividend announcements by Biocon Ltd. 532523

Biocon Ltd. 532523 listed on BSE and deals in

Announcements and dividends declared by Biocon Ltd. 532523

Biocon Q3FY26 results: Revenue up 9%, net profit rises on generics push
Board gives in-principle nod to make Biocon Biologics a wholly owned subsidiary as Q3 net profit climbs to Rs 143.8 crore
Announcement as on 12 February 2026

S&P Global upgrades Biocon Biologics ratings
S&P Global Ratings on Wednesday upgraded Biocon Biologics ratings with a stable outlook.
Announcement as on 28 January 2026

Biocon QIP to ease balance sheet pressure; metals, PSU banks favoured in near term: Nischal Maheshwari
Biocon's fundraising is viewed positively to manage debt. Expert Nischal Maheshwari is optimistic about Biocon's future, expecting earlier investments to yield returns. He also favors contract development and manufacturing firms like Laurus Labs. Maheshwar
Announcement as on 13 January 2026

Biocon arm gets USFDA nod for generic Everolimus tablets
Biocon's arm, Biocon Pharma Ltd, has secured USFDA approval for its generic Everolimus tablets. This medication aids in treating tuberous sclerosis complex, a rare genetic disorder causing tumors. The approval for 2mg, 3mg, and 5mg strengths bolsters Bioco
Announcement as on 12 January 2026

Biocon Biologics gets global rights for biosimilar Adalimumab
Biocon Biologics has gained complete global rights for Hulio, a biosimilar Adalimumab. This move grants Biocon Biologics full control over manufacturing and commercialization. The company aims to expand affordable access to high-quality biologics for patie
Announcement as on 23 December 2025

Announcements by Biocon Ltd. first page | Next page |

532523 Biocon Ltd. current price & indicator signals

Moving Averages for Biocon Ltd.

  • 5Day Average: 376
  • 12Day Average: 372.24
  • 20Day Average: 370.23
  • 50Day Average: 380.33
  • 100Day Average: 377.79
  • 150Day Average: 375.33
  • 200Day Average: 367.47

532523 Indicators & signals

Indicator MACD (12,26,9)

373.78, 374.63, -2.82
Indicator MACD is in negative zone

Indicator ADX (14)

26.01, 24.81, 14.57
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 48
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 532523 Biocon Ltd. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
16 Mon Feb 2026 380.25 374.80 to 384.15 0.65% 0.56 times
13 Fri Feb 2026 377.80 369.50 to 382.00 0.68% 2.99 times
12 Thu Feb 2026 375.25 371.20 to 389.20 -0.15% 2.55 times
11 Wed Feb 2026 375.80 367.50 to 376.95 1.32% 0.32 times
10 Tue Feb 2026 370.90 367.00 to 374.90 -0.8% 0.3 times
09 Mon Feb 2026 373.90 366.45 to 375.10 2.38% 0.36 times
06 Fri Feb 2026 365.20 361.30 to 369.70 -0.68% 0.23 times
05 Thu Feb 2026 367.70 363.30 to 368.95 -0.26% 0.57 times
04 Wed Feb 2026 368.65 366.00 to 376.35 -0.97% 0.49 times
03 Tue Feb 2026 372.25 370.80 to 388.90 0.43% 1.57 times
02 Mon Feb 2026 370.65 360.80 to 372.30 0.57% 0.63 times
01 Sun Feb 2026 368.55 362.50 to 377.30 0.55% 1.77 times

Videos related to: 532523 announcements Biocon Ltd. announcements and dividends declared BSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

532523 announcements Biocon Ltd. announcements and dividends declared BSE

 

Back to top